Eli Lilly and Alchemab Therapeutics have partnered to develop new therapies for amyotrophic lateral sclerosis (ALS). The ...

The voice of Israeli journalist Moshe Nussbaum has been revived using artificial intelligence after he was diagnosed with ALS.

The Vermont Department of Health recently released data from the state's first registry for the disease Amyotrophic Lateral ...

When a renowned Israeli TV journalist lost his ability to speak clearly because of ALS, he thought his career might be over.

The following is a summary of “Education moderates the association between motor involvement and executive status in ALS,” published in the December 2024 issue of Neurology by Aiello et al.

Ancient Viral DNA in the Human Genome Linked to Multiple Sclerosis and Amyotrophic Lateral Sclerosis Oct ... developing multiple sclerosis (MS) than people who have spent a smaller proportion ...

Renowned Israeli journalist with ALS uses AI to recreate voice, making a comeback after losing ability to speak.

Synchron announced today that it expanded its partnership with Team Gleason to raise awareness for its brain-computer ...

Denali Therapeutics said on Monday its experimental drug failed to meet the main goal of a mid-to-late stage trial involving patients with amyotrophic lateral sclerosis (ALS), a fatal ...

Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future ...